Literature DB >> 18926942

Breast cancer stem cells and tumor suppressor genes.

Wendy W Hwang-Verslues1, King-Jen Chang, Eva Y-H P Lee, Wen-Hwa Lee.   

Abstract

Studies of breast cancer stem cells are in their infancy and many fundamental questions have yet to be fully addressed. The molecular distinction between normal and cancerous breast stem cells is not clear. While there have been recent breakthroughs in mouse mammary stem cells and lineage determination in mammary glands, little has been determined in human cells. Microarray analyses have provided molecular categorization of breast cancer. However, the cellular origin of different types of breast cancer is largely unknown. In addition, the relationship between breast cancer stem cells and mammary progenitor cells has yet to be clarified. One of the key questions is how a normal mammary stem cell becomes a breast cancer stem cell. Importantly, the existence of different types of human breast cancers with distinct pathologic and molecular signatures suggests the possibility that different types of breast cancer stem cells may exist. Here, we aim to review the current evidence for the existence of different subtypes of breast cancer stem cells and provide further insight into how tumor suppressors might be involved in the initiation of breast cancer stem cells.

Entities:  

Mesh:

Year:  2008        PMID: 18926942     DOI: 10.1016/S0929-6646(08)60188-6

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  5 in total

1.  Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers.

Authors:  Wendy W Hwang-Verslues; Wen-Hung Kuo; Po-Hao Chang; Chi-Chun Pan; Hsing-Hui Wang; Sheng-Ta Tsai; Yung-Ming Jeng; Jin-Yu Shew; John T Kung; Chung-Hsuan Chen; Eva Y-H P Lee; King-Jen Chang; Wen-Hwa Lee
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

2.  Expression distribution of cancer stem cells, epithelial to mesenchymal transition, and telomerase activity in breast cancer and their association with clinicopathologic characteristics.

Authors:  Jaafar Makki; Ohnmar Myint; Aye Aye Wynn; Ahmad Toha Samsudin; Daisy Vanitha John
Journal:  Clin Med Insights Pathol       Date:  2015-01-07

3.  Effect of bFGF on the MCF-7 Cell Cycle with CD44(+)/CD24(-): Promoting the G0/G1→G2/S Transition.

Authors:  Zhen-Lin Yang; Kai Cheng; Zhao-Dong Han
Journal:  J Breast Cancer       Date:  2012-12-31       Impact factor: 3.588

4.  Biomarkers to Target Heterogeneous Breast Cancer Stem Cells.

Authors:  Wendy W Hwang-Verslues; Wen-Hwa Lee; Eva Y-H P Lee
Journal:  J Mol Biomark Diagn       Date:  2012

5.  Kruppel-like factor 4 signals through microRNA-206 to promote tumor initiation and cell survival.

Authors:  C-C Lin; S B Sharma; M K Farrugia; S L McLaughlin; R J Ice; Y V Loskutov; E N Pugacheva; K M Brundage; D Chen; J M Ruppert
Journal:  Oncogenesis       Date:  2015-06-08       Impact factor: 7.485

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.